GEN Exclusives

More »

GEN News Highlights

More »
Oct 29, 2009

Proven Diagnostics to Provide Cardiovascular Tests from Berkeley HeartLab

  • Proven Diagnostics will provide select diagnostic tools from Berkeley HeartLab’s (BHL) menu of cardiovascular tests and services. The co-marketing agreement includes BHL’s 4myheart cardiovascular disease management program. 

    Proven Diagnostics will be the first external clinical laboratory to have access to KIF6, BHL’s genetic test. The KIF6 gene encodes kinesin-like protein 6 (KIF6), which is thought to be associated with cardiovascular risk and statin benefit. Testing under the agreement will be performed by BHL.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?